https://stock.noler.com/us/stock/sorrento-therapeutics-inc https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accounts-payable-interest-bearing-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accounts-payable-related-parties-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accretion-of-discount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/acquired-intangibles https://stock.noler.com/us/stock/sorrento-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/sorrento-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/sorrento-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/sorrento-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sorrento-therapeutics-inc/adjustment-for-amortization https://stock.noler.com/us/stock/sorrento-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/allowance-for-doubtful-other-receivables-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/sorrento-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/sorrento-therapeutics-inc/amortization https://stock.noler.com/us/stock/sorrento-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/sorrento-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/aoci https://stock.noler.com/us/stock/sorrento-therapeutics-inc/asset-acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/sorrento-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/bankruptcy-claims-number-claims-filed https://stock.noler.com/us/stock/sorrento-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisition-purchase-price-allocation-current-liabilities-accounts-payable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisitions-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/sorrento-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/sorrento-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sorrento-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/sorrento-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/sorrento-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/sorrento-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/sorrento-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sorrento-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cost-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cost-method-investments-realized-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/costmethod-investments-other-than-temporary-impairment https://stock.noler.com/us/stock/sorrento-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sorrento-therapeutics-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-basis-spread-on-variable-rate-1 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-fee-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-interest-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-securities-trading-realized-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debtor-in-possession-financing-amount-arranged https://stock.noler.com/us/stock/sorrento-therapeutics-inc/debtor-reorganization-items-debtor-in-possession-facility-financing-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-credits-and-other-liabilities-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-revenue-2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-revenue-change https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-derivative-instruments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-reserves https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/deferred-tax-liabilities-unrealized-gains-on-trading-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/depreciation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/sorrento-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-gain-on-derivative https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-liability-notional-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/derivative-loss-on-derivative https://stock.noler.com/us/stock/sorrento-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/sorrento-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/sorrento-therapeutics-inc/dividends-paid https://stock.noler.com/us/stock/sorrento-therapeutics-inc/dividends-stock https://stock.noler.com/us/stock/sorrento-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sorrento-therapeutics-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/eps https://stock.noler.com/us/stock/sorrento-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-method-investment-other-than-temporary-impairment https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-method-investment-realized-gain-loss-on-disposal https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-securities-fv-ni https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-securities-fv-ni-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-securities-fv-ni-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/equity-securities-fvni-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/sorrento-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-customer-relationships-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/form-d-corporate-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gain-loss-on-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gain-loss-on-sale-of-notes-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/sorrento-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-change https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/grants-receivable-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/sorrento-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/sorrento-therapeutics-inc/impairment-of-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-tax-examination-interest-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-tax-expense-benefit-adjustment-of-deferred-tax-asset-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/sorrento-therapeutics-inc/income-taxes-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/sorrento-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/sorrento-therapeutics-inc/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/sorrento-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/sorrento-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/sorrento-therapeutics-inc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/sorrento-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/sorrento-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/sorrento-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/inventory https://stock.noler.com/us/stock/sorrento-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/sorrento-therapeutics-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/sorrento-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/sorrento-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/sorrento-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/sorrento-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/sorrento-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/sorrento-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/legal-fees https://stock.noler.com/us/stock/sorrento-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sorrento-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/sorrento-therapeutics-inc/level-3-liability-purchases https://stock.noler.com/us/stock/sorrento-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/sorrento-therapeutics-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/sorrento-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/liabilities-subject-to-compromise https://stock.noler.com/us/stock/sorrento-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/sorrento-therapeutics-inc/loans-and-leases-receivable-related-parties-change https://stock.noler.com/us/stock/sorrento-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/loss-in-period https://stock.noler.com/us/stock/sorrento-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/marketable-securities-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/marketable-securities-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/marketable-securities-realized-gain-loss-other-than-temporary-impairments-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/minority-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/sorrento-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/sorrento-therapeutics-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/sorrento-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/noncontrolling-interest-increase-from-sale-of-parent-equity-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/noncontrolling-interest-increase-from-subsidiary-equity-issuance https://stock.noler.com/us/stock/sorrento-therapeutics-inc/nonoperating-gains-losses https://stock.noler.com/us/stock/sorrento-therapeutics-inc/notes-receivable-related-parties https://stock.noler.com/us/stock/sorrento-therapeutics-inc/notes-receivable-related-parties-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-available-for-sale-adjustment-before-reclassification-adjustments-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-deferred-credits-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-liabilities-and-deferred-revenue-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/sorrento-therapeutics-inc/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/sorrento-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/sorrento-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/patents-active https://stock.noler.com/us/stock/sorrento-therapeutics-inc/patents-pending https://stock.noler.com/us/stock/sorrento-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-to-acquire-interest-in-joint-venture https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sorrento-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/sorrento-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/sorrento-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-loan-originations https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/sorrento-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/sorrento-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/sorrento-therapeutics-inc/public-float https://stock.noler.com/us/stock/sorrento-therapeutics-inc/realized-gains-on-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/reimbursement-revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/sorrento-therapeutics-inc/related-party-transaction-purchases-from-related-party https://stock.noler.com/us/stock/sorrento-therapeutics-inc/related-party-transaction-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/reorganization-items https://stock.noler.com/us/stock/sorrento-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/repayments-of-senior-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/sorrento-therapeutics-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/sorrento-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/sorrento-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/sorrento-therapeutics-inc/restricted-cash-and-investments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/sorrento-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/sorrento-therapeutics-inc/revenue https://stock.noler.com/us/stock/sorrento-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/sorrento-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/sorrento-therapeutics-inc/revenue-from-related-parties https://stock.noler.com/us/stock/sorrento-therapeutics-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/sorrento-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sales-revenue-services-net https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-comment-letters-sec-staff-letter https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-certnas https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-def-14c https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-defn14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-defr14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-pren14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-prrn14a https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sec-filings-sec-staff-action https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-424b7 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/sorrento-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/share-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/shares-repurchased https://stock.noler.com/us/stock/sorrento-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/sorrento-therapeutics-inc/standardized-measure-of-discounted-future-net-cash-flow-relating-to-proved-oil-and-gas-reserves-accretion-of-discount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/standardized-measure-of-discounted-future-net-cash-flow-relating-to-proved-oil-and-gas-reserves-accretion-of-discount-2 https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/sorrento-therapeutics-inc/stockholders-equity-other https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/sorrento-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/sorrento-therapeutics-inc/taxes-payable-current https://stock.noler.com/us/stock/sorrento-therapeutics-inc/total-assets https://stock.noler.com/us/stock/sorrento-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sorrento-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/sorrento-therapeutics-inc/trading-securities https://stock.noler.com/us/stock/sorrento-therapeutics-inc/trading-securities-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/trading-securities-realized-gain-loss https://stock.noler.com/us/stock/sorrento-therapeutics-inc/treasury-shares-acquired https://stock.noler.com/us/stock/sorrento-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/treasury-stock-cost https://stock.noler.com/us/stock/sorrento-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/sorrento-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/sorrento-therapeutics-inc/undistributed-earnings-loss-available-to-common-shareholders-diluted https://stock.noler.com/us/stock/sorrento-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-decrease-from-acquisition https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-decrease-from-foreign-currency-translation https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/sorrento-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/sorrento-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sorrento-therapeutics-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/sorrento-therapeutics-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/sorrento-therapeutics-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/sorrento-therapeutics-inc/valuation-allowances-and-reserves-reserves-of-businesses-acquired https://stock.noler.com/us/stock/sorrento-therapeutics-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/sorrento-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted